MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TN-03-0082587
Codak Pharmaceuticals (OPC) Private Limited
Codak Pharmaceuticals (OPC) Private Limited - healthcare in Coimbatore, Tamil Nadu, India. Directors, charges & compliance details.
Revenue · FY 2025
₹22.28 Lakh
▲ 87% YoY
Net profit · FY 2025
₹34,318
Net margin 1.5%
EBITDA · FY 2025
₹46,377
EBITDA margin 2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
1
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Codak Pharmaceuticals (OPC) Private Limited
Data last updated:
Codak Pharmaceuticals (OPC) Private Limited is a one person company based in Coimbatore, Tamil Nadu, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 21 March 2022.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U51909TZ2022OPC038472.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by director Khateeja Faheemahmed (Managing Director).
Its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 5 – 4 Manchester Perks Apartments Uppilipalayam Coimbator, Coimbatore, Tamil Nadu, India – 641015.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.28 Lakh, a growth of 87% compared to the previous year. For the same year it recorded a net profit of ₹34,318 (net margin 1.5%) and EBITDA of ₹46,377 (EBITDA margin 2.1%).
Codak Pharmaceuticals (OPC) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-03-0082587).
Company Details of Codak Pharmaceuticals (OPC) Private Limited
CIN U51909TZ2022OPC038472
Registration Number 038472
Incorporation Date 21 March 2022
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TN-03-0082587
Key People
Khateeja Faheemahmed Managing Director Recognitions & Rankings of Codak Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No – 5 – 4 Manchester Perks Apartments Uppilipalayam Coimbator, Coimbatore, Tamil Nadu, India – 641015
- IndustryHealthcare, Medical Equipment Retail & Distribution
Comprehensive company report
Codak Pharmaceuticals (OPC) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Codak Pharmaceuticals (OPC) Private Limited
The main business activity of Codak Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Codak Pharmaceuticals (OPC) Private Limited FY 2025 filings available
Codak Pharmaceuticals (OPC) Private Limited reported revenue of ₹22.28 Lakh (up 87% YoY) for FY 2025.
Revenue · FY 2025
₹22.28 Lakh ▲ 87%
Net profit · FY 2025
₹34,318 margin 1.5%
EBITDA · FY 2025
₹46,377 margin 2.1%
Compounded Annual Growth Rate (CAGR) of Codak Pharmaceuticals (OPC) Private Limited
Revenue CAGR growth
1 year
▲ 87%
EBITDA CAGR growth
1 year
▲ 156%
Revenue rose 87% in the latest year. EBITDA rose 156% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Codak Pharmaceuticals (OPC) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹46,377 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹34,318 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Codak Pharmaceuticals (OPC) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.1% | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Codak Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Codak Pharmaceuticals (OPC) Private Limited
Codak Pharmaceuticals has 1 director on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khateeja Faheemahmed | Managing Director | 21 Mar 2022 | 4 Years 6 Months | Current |
Peer Comparison of Codak Pharmaceuticals (OPC) Private Limited
Codak Pharmaceuticals (OPC) Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bonton Pharmaceuticals Private Limited | ₹22.4 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Gwalior, Madhya Pradesh, India |
| Ag-Tuscan Pharmaceuticals (OPC) Private Limited | ₹22.39 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | Chandigarh, India |
| Madis Pharmaceuticals Private Limited | ₹22.34 Lakh (FY 2023) | •••• | •••• | 346.0% | •••• | Hyderabad, Telangana, India |
| Hardyz Pharmaceuticals Private Limited | ₹22.3 Lakh (FY 2025) | •••• | •••• | 287.0% | •••• | Pune, Maharashtra, India |
| Dib Brothers Private Limited | ₹22.29 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Delhi, India |
| Codak Pharmaceuticals (OPC) Private Limited this company | ₹22.28 Lakh (FY 2025) | •••• | •••• | 87.0% | •••• | Coimbatore, Tamil Nadu, India |
| Analytica Labchem Private Limited | ₹22.25 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Stedel Pharmaceuticals Private Limited | ₹22.24 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Jhansi, Uttar Pradesh, India |
| Hexalin Pharmaceuticals Private Limited | ₹22.22 Lakh (FY 2024) | •••• | •••• | 49.0% | •••• | Raipur, Chhattisgarh, India |
| Xlinar Pharmaceuticals Private Limited | ₹22.18 Lakh (FY 2025) | •••• | •••• | •••• | Murshidabad, West Bengal, India | |
| Tripurrte Pharmaceuticals Private Limited | ₹22.16 Lakh (FY 2024) | •••• | •••• | 257.0% | •••• | Rajalingam Residency, Pha, Telangana, India |
Peers are the five companies nearest above and the five nearest below Codak Pharmaceuticals by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Codak Pharmaceuticals (OPC) Private Limited
Codak Pharmaceuticals (OPC) Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Codak Pharmaceuticals (OPC) Private Limited
Employment history and EPFO contributions of people linked to Codak Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Codak Pharmaceuticals (OPC) Private Limited
Codak Pharmaceuticals (OPC) Private Limited has 1 board change on record since 2022: 1 appointment. The latest: Khateeja Faheemahmed was appointed as Managing Director on 21 Mar 2022.
Filing
Codak Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Coimbatore.
Appointed
Khateeja Faheemahmed was appointed as Managing Director.
Incorporation
21 Mar 2022
Codak Pharmaceuticals (Opc) Private Limited was registered on 21 Mar 2022 with Roc Coimbatore & aged 4 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Codak Pharmaceuticals (OPC) Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Codak Pharmaceuticals (OPC) Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Codak Pharmaceuticals (OPC) Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Codak Pharmaceuticals (OPC) Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Codak Pharmaceuticals (OPC) Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Codak Pharmaceuticals (OPC) Private Limited
Codak Pharmaceuticals is an active company based in Coimbatore, Tamil Nadu, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 21 March 2022 (4+ years old) and is registered under CIN U51909TZ2022OPC038472.
Codak Pharmaceuticals reported revenue of ₹22.28 Lakh for FY 2025 (up 87% YoY).
Codak Pharmaceuticals has 1 current director:
- Khateeja Faheemahmed - Managing Director
Codak Pharmaceuticals reported a net profit of ₹34,318 (net margin 1.5%) and EBITDA of ₹46,377 (EBITDA margin 2.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Codak Pharmaceuticals is U51909TZ2022OPC038472. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Codak Pharmaceuticals was incorporated on 21 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Codak Pharmaceuticals by revenue are Bonton Pharmaceuticals Private Limited, Ag-Tuscan Pharmaceuticals (OPC) Private Limited, Madis Pharmaceuticals Private Limited, Hardyz Pharmaceuticals Private Limited, Dib Brothers Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals).
Khateeja Faheemahmed was appointed as Managing Director on 21 Mar 2022.
Yes, Codak Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-03-0082587).
The registered office of Codak Pharmaceuticals is at Flat No – 5 – 4 Manchester Perks Apartments Uppilipalayam Coimbator, Coimbatore, Tamil Nadu, India – 641015.
Codak Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh.